5-methyluridine (ribothymidine)

5-methyluridine (ribothymidine) (CAS No.: 1463-10-1) is an endogenous methylated pyrimidine nucleoside and a well-characterized RNA modification generated by RNA methyltransferases, including TrmA and RumA, which selectively modify uracil residues within structured regions of tRNA and rRNA such as the T loop and specific stem–loop motifs. This modification contributes to the stabilization of RNA secondary and tertiary structures, thereby influencing base pairing fidelity, translation accuracy, and ribosome function, and ultimately playing a critical role in protein synthesis and cellular homeostasis. As a naturally occurring metabolite detected in human biological fluids, 5-methyluridine is also implicated in the regulation of signaling pathways and enzymatic activities associated with cell proliferation and metabolic processes. In biochemical and pharmacological research, it is widely used as a tool compound for studying RNA modification dynamics, nucleoside metabolism, and enzyme function, including assays involving nucleosidases and methyltransferases. Experimental evidence further suggests that it can enhance the antitumor efficacy of chemotherapeutic agents such as 5-fluorouracil in preclinical cancer models, supporting its relevance in combination therapy studies. Although precise potency metrics are context-dependent, its biological effects are typically observed in the nanomolar to micromolar range in vitro, with experimental concentrations or dosing regimens varying according to specific study designs.